Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 7 of 24, showing 5 Applications out of 117 total, starting on record 31, ending on 35

# Protocol No Study Title Investigator(s) & Site(s)

31.

ECCT/23/05/01   A5356
    A Phase II, Prospective, Randomized, Multicenter Trial to Evaluate the Efficacy and Safety/Tolerability of Two Linezolid Dosing Strategies in Combination with a Short Course Regimen for the Treatment of Drug-Resistant Pulmonary Tuberculosis   
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
MOI UNIVERSITY CLINICAL RESEARCH CENTRE
 
View

32.

ECCT/22/11/02   UNCPM 22120 5-FU Study
    UNCPM  22120: Safety of adjuvant, self-administered intravaginal 5-fluorouracil (5-FU) cream following cervical intraepithelial neoplasia grade 2 and 3 (CIN2/3) treatment among HIV-positive women in Kenya: A pilot study   
Principal Investigator(s)
1. Elizabeth Anne Bukusi
2. Chemtai Mungo
Site(s) in Kenya
Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH)
 
View

33.

ECCT/23/03/01   Micronutrient supplementation
    Optimizing nutrient supplementation among pregnant and reproductive age women in Kenya (Virutubisho)   
Principal Investigator(s)
1. DR. Martha Kaeni Mwangome
Site(s) in Kenya
KILIFI
 
View

34.

ECCT/23/03/07   PLATINUM STUDY
    (PLATINUM): A multi-part, multi-center PLATform study to assess the efficacy, safety, tolerability and pharmacokinetics of anti-malarial agents administered as monotherapy and/or combination therapy IN patients with Uncomplicated Plasmodium falciparum Malaria   
Principal Investigator(s)
1. Godfrey (Site 5001) Allan Otieno
2. Bernhard Ragama Ogutu
3. John (Site 5002) Orimbo
Site(s) in Kenya
1. KEMRI Kondele Children Hospital (Kisumu county)
2. AHERO CLINICAL TRIALS UNIT (Kisumu county)
 
View

35.

ECCT/16/08/03   IMPAACT 2001
    A Phase I/II Trial of the Pharmacokinetics, Tolerability, and Safety of Once-Weekly Rifapentine and Isoniazid in HIV-1-infected and HIV-1-uninfected Pregnant and Postpartum Women with Latent Tuberculosis Infection   
Principal Investigator(s)
1. Deborah Chepngeno Langat
Site(s) in Kenya
Kenya Medical Research Institute Walter Reed project
 
View